Triple therapy inhalers are expected to account for 11.3% of the total market. The chronic obstructive pulmonary disease ...

Pressurized metered-dose inhalers (pMDIs) for COPD and asthma contribute to climate change, and countries are moving away from their use.

With Chronic Breathing Issues on the Rise, AirPhysio Emerges as a Breakthrough Drug-Free Device Helping Millions Naturally ...

Ohtuvayre is the first new inhaled COPD therapy approved in over two decades. COPD is a chronic inflammatory condition that ...

The global aerosol delivery devices market was valued at $31,463.9 million in 2019, and is projected to reach $46,728.7 million by 2027, registering a CAGR of 4.9% from 2020 to 2027. Rise in ...

With Medicare coverage, a person can still have certain out-of-pocket costs for an inhaler. Out-of-pocket cost: This is the amount a person must pay for care when Medicare does not pay the total ...

Bacterial colonisation is an important predictor of exacerbation in AATD-COPD and may require additional targeted therapy, ...

smart inhalers market report highlights transformative digital innovations in respiratory care, improved patient adherence, and forecasted growth through 2035 ...

Long-distance caregivers can help manage a loved one’s finances, organize their medical appointments, coordinate with other ...

Chronic lower respiratory diseases, namely, asthma and chronic obstructive pulmonary disease , are the fifth-leading cause of ...

A procedure at Arnot Health is looking to help patients who are dealing with breathing issues and is said to be an option in ...